Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Buy Dr Lal Pathlabs; target of Rs 3100: Emkay

      Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 3100 in its research report dated July 20, 2025.

    • Hold Dr Lal Pathlabs: target of Rs 2,900: ICICI Securities

      ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 2,900 in its research report dated April 26, 2025.

    • Buy Dr Lal Pathlabs; target of Rs 3100: Emkay Global Financial

      Emkay Global Financial recommended buy rating on Dr Lal Pathlabs with a target price of Rs 3100 in its research report dated April 26, 2025.

    • Buy Dr Lal Pathlabs; target of Rs 3250: Emkay Global Financial

      Emkay Global Financial is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 3250 in its research report dated January 30, 2025.

    • Hold Dr Lal Pathlabs; target of Rs 3100: ICICI Securities

      ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 3100 in its research report dated October 24, 2024.

    • Hold Dr Lal Pathlabs; target of Rs 3,240: ICICI Securities

      ICICI Securities recommended hold rating on Dr Lal Pathlabs with a target price of Rs 3,240 in its research report dated August 08, 2024.

    • Buy Dr Lal Pathlabs; target of Rs 2800: Emkay

      Emkay is bullish on Dr Lal Pathlabs has recommended buy rating on the stock with a target price of Rs 2800 in its research report dated May 10, 2024.

    • Hold Dr. Lal PathLabs; target of Rs 1995: Geojit

    • Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas Lilladher

    • Sell Dr. Lal PathLabs; target of Rs 895: Prabhudas Lilladher

    • Accumulate Dr. Lal PathLabs; target of Rs 1120: Prabhudas Lilladher

    • Accumulate Dr. Lal PathLabs; target of Rs 1070: Prabhudas Lilladher

    • Accumulate Dr. Lal PathLabs; target of Rs 1009: Prabhudas Lilladher

    • Accumulate Dr. Lal PathLabs; target of Rs 1009: Prabhudas Lilladher

    • Dr Lal, Rallis India & Ceat among 5 safe midcaps you can bet on

    • Buy Dr. Lal Pathlabs; target of Rs 1230: Edelweiss

    Advisory Alert:

    It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347